Johan Luthman is the Executive Vice President and Head of R&D at Lundbeck, where they lead a talented team dedicated to advancing neuroscience research and developing novel medicines aimed at improving brain health. With a background that includes significant roles at companies like Eisai, Merck Serono, and AstraZeneca, Johan's expertise encompasses R&D line management, project leadership, and program management in both neuroscience and immunology. Johan earned a DDS and PhD from Karolinska Institutet, contributing to their extensive knowledge in the field.